PNC Financial Services Group’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Buy |
|
|||||
|
2025
Q1 | $133K | Buy |
|
|||||
|
2024
Q4 | $73K | Buy |
|
|||||
|
2024
Q3 | $63.8K | Buy |
|
|||||
|
2024
Q2 | $41.9K | Buy |
|
|||||
|
2024
Q1 | $41.2K | Sell |
|
|||||
|
2023
Q4 | $218K | Buy |
|
|||||
|
2023
Q3 | $131K | Buy |
|
|||||
|
2023
Q2 | $106K | Buy |
|
|||||
|
2023
Q1 | $52.4K | Buy |
|
|||||
|
2022
Q4 | $57.6K | Buy |
|
|||||
|
2022
Q3 | $36K | Buy |
|
|||||
|
2022
Q2 | $2K | Hold |
|
|||||
|
2022
Q1 | $4K | Hold |
|
|||||
|
2021
Q4 | $2K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.38M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $3K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $4K | Buy |
|